The Oncology Institute, Inc. (STLN) Price Prediction & ForecastSTLNThe Oncology Institute, Inc.

Alphio's STLN stock price prediction model matches the current The Oncology Institute, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.51 (-0.38%). The 1-week path is $6.62 (+1.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Starling Oncology, Inc. appears to be a good buy right now, especially considering its recent performance and growth trajectory. The current price is $6.71, which is well below the projected upper band of $7.34 based on Fibonacci levels, indicating potential for upward movement. Additionally, the stock has shown a year-to-date change of +30.80%, reflecting strong momentum. However, the main risk is the negative net income, which was -$9,789,000 in Q2 2026, indicating ongoing financial challenges that investors should monitor closely.

The Oncology Institute, Inc. (STLN) last closed at $6.5300002, losing -1.80%. These facts feed the 1-day and 1-week STLN price prediction above.